Overview

This trial is active, not recruiting.

Conditions social anxiety, substance use
Treatment reduction of social anxiety & substance use in gay/bi men
Phase phase 1
Sponsor Ryerson University
Start date February 2013
End date October 2017
Trial size 20 participants
Trial identifier NCT02045225, 201203HHP-279414, 201203HHP-279414-PB1ABAF146056

Summary

Men who have sex with men (MSM) bear a disproportionate burden of the Human Immunodeficiency Virus (HIV) epidemic in Canada, and HIV incidence appears to be rising among Canadian MSM (1). MSM comprised nearly half (44.1%) of new positive HIV tests in 2009 (2). Among MSM in Ontario, from 2001 to 2006, HIV diagnoses increased 26% (3). Given the alarmingly high HIV prevalence rates among MSM in North American cities, there is a critical need for HIV prevention interventions for MSM in Canada. Social anxiety, or anxiety about being evaluated in interpersonal situations, is a reliable risk factor for unprotected anal intercourse (UAI) among MSM (4 and 5). Social anxiety is highly modifiable via cognitive-behavioural therapy, a form of psychotherapy (6). Social anxiety may also increase substance use in sexual situations, which is another risk factor for HIV among MSM (7 and 8). As such, an empirically-based social anxiety treatment may also reduce HIV risk behaviours among MSM. The present study will provide Phase I trial data for a novel and innovative HIV prevention intervention for MSM. This is a proposal to test a novel integrated HIV prevention intervention that combines empirically supported treatments for social anxiety with HIV risk reduction counseling to reduce HIV sexual risk behaviour.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose prevention
Arm
(Experimental)
Reduction of social anxiety & substance use in gay/bi men
reduction of social anxiety & substance use in gay/bi men
The study will provide Phase I trial data for a novel and innovative HIV prevention intervention for MSM built upon empirically supported interventions to reduce HIV risk among MSM and cognitive-behavioural therapy to reduce social anxiety. This study will test a novel integrated HIV prevention intervention that combines empirically supported treatments for social anxiety with HIV risk reduction counseling to reduce HIV sexual risk behaviour. Study objectives: 1) to provide data on the acceptability/feasibility of the intervention, 2) to provide data to test the intervention, and 3) to provide data that will allow for a RCT that will test intervention efficacy relative to HIV prevention interventions that do not reduce social anxiety or substance use in sexual situations.

Primary Outcomes

Measure
Instances of unprotected anal intercourse with sexual partners who are HIV-positive or of unknown HIV status
time frame: 3, 6, and 9 months following baseline assessment

Secondary Outcomes

Measure
Severity of social anxiety and instances substance use in sexual situations
time frame: 3, 6, and 9 months after baseline assessment

Eligibility Criteria

Male participants from 18 years up to 65 years old.

Inclusion Criteria: - aged 18-65 years - male identified - gay or bisexual identified - experiencing social anxiety in sexual situations - condomless anal sex with a casual (or non-monogamous) HIV-positive or unknown serostatus partner in the last 3 months - consumption of alcohol and/or a recreational drug within 2 hours before sex or during sex within the last 3 months Exclusion Criteria: - younger than 18 or older than 65 years of age - not male identified - sexual orientation other than gay or bisexual - no experiences of social anxiety in sexual situations - severe mental illness - already receiving psychotherapy

Additional Information

Official title An HIV Prevention Intervention for HIV-negative Men Who Have Sex With Men Via Reduction of Social Anxiety and Substance Use in Sexual Situations
Principal investigator Trevor A Hart, PhD
Description The present study will provide pilot data for a novel and innovative HIV prevention intervention for MSM. This intervention will build upon empirically supported interventions to reduce HIV risk among MSM and cognitive-behavioural therapy to reduce social anxiety. This pilot study will serve 3 related major objectives: 1) to provide data on the acceptability and feasibility of the intervention administered, 2) to provide pilot data testing the intervention, and 3) to provide data that will allow Dr. Hart and his team to apply to CIHR for a Phase II trial that will test the efficacy of the intervention relative to HIV prevention interventions that do not reduce social anxiety or substance use in sexual situations among MSM. Participants attend 4 assessment sessions, during which they complete a series of interviews and questionnaires regarding social anxiety, substance use, and sexual risk behaviours. Participants also attend 10 sessions of counselling, where a therapist seeks to help the participant work towards reducing his anxiety in social and sexual situations and try to better manage his use of alcohol and drugs in sexual situations. The participant undergoes a baseline assessment, followed by 10 weekly counselling sessions, a post-treatment assessment, and 3- and 6-month follow-up assessments.
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by Ryerson University.